keyword
https://read.qxmd.com/read/38676588/-a-case-of-thyroid-gland-abscess-caused-by-brucella-melitensis
#41
JOURNAL ARTICLE
Ilgaz Kazaz, Ertuğrul Yazici, İsmail Selçuk Aygar, Tuğrul Hoşbul
Brucellosis is a zoonotic disease endemic in many developing countries, including Türkiye. Among the species that are pathogenic for humans; Brucella melitensis is isolated from livestock animals like sheep and goats, Brucella abortus from cattle and Brucella suis from pigs. Laboratory diagnosis of infection caused by Brucella species with gram-negative coccobacillus morphology; can be made through characteristic culture features, serological tests and molecular methods. Brucellosis, which has a wide distribution of clinical signs and symptoms; can cause various complications by affecting many organs and systems...
April 2024: Mikrobiyoloji Bülteni
https://read.qxmd.com/read/38675486/development-and-validation-of-a-capillary-zone-electrophoresis-tandem-mass-spectrometry-method-for-simultaneous-quantification-of-eight-%C3%AE-lactam-antibiotics-and-two-%C3%AE-lactamase-inhibitors-in-plasma-samples
#42
JOURNAL ARTICLE
Ivana Cizmarova, Peter Mikus, Martin Svidrnoch, Juraj Piestansky
Monitoring plasma concentrations of β-lactam antibiotics is crucial, particularly in critically ill patients, where variations in concentrations can lead to treatment failure or adverse events. Standardized antimicrobial regimens may not be effective for all patients, especially in special groups with altered physiological parameters. Pharmacokinetic/pharmacodynamic (PK/PD) studies highlight the time-dependent antibacterial activity of these antibiotics, emphasizing the need for personalized dosing. Therapeutic drug monitoring (TDM) is essential, requiring rapid and accurate analytical methods for precise determination of drugs in biological material (typically plasma or serum)...
April 19, 2024: Pharmaceuticals
https://read.qxmd.com/read/38674593/topical-antibiotic-therapy-in-the-ocular-environment-the-benefits-of-using-moxifloxacin-eyedrops
#43
REVIEW
Lorenzo Drago
Moxifloxacin is a fourth-generation fluoroquinolone antibiotic available for ophthalmic use. It inhibits two enzymes involved in bacterial DNA synthesis, covering Gram-positive and Gram-negative pathogens. This spectrum allows for the formulation of self-preserving bottle solutions, while its interesting pharmacological profile is distinguished by efficacy at low tissue concentrations and by an infrequent dose regimen due to its long duration on ocular tissues. This enhances patient compliance, promoting its use in children...
March 25, 2024: Microorganisms
https://read.qxmd.com/read/38671341/a-comparative-study-of-general-and-severe-mycoplasma-pneumoniae-pneumonia-in-children
#44
COMPARATIVE STUDY
Shuo Yang, Sukun Lu, Yinghui Guo, Wenjun Luan, Jianhua Liu, Le Wang
OBJECTIVES: The increasing prevalence of severe Mycoplasma pneumoniae pneumonia (SMPP) poses a significant threat to the health of children. This study aimed to characterise and assess the outcomes in children with SMPP. METHODS: We retrospectively analysed children hospitalised for M. pneumoniae pneumonia (MPP) between January and December 2022. Retrospectively, demographic, clinical, underlying diseases, laboratory and radiological findings, and treatment outcomes were collected and analysed...
April 26, 2024: BMC Infectious Diseases
https://read.qxmd.com/read/38668813/current-perspective-on-infections-and-mitigation-strategies-in-primary-systemic-vasculitis
#45
REVIEW
Manuel Carpio Tumba, Raisa Lomanto Silva, Ana B Arevalo, Sebastian E Sattui
PURPOSE OF REVIEW: The purpose of this review is to summarize and evaluate most recent evidence on the epidemiology of infections and associated risk factors in patients with primary systemic vasculitides (PSV), as well as discuss mitigation strategies including the risk of antibiotic prophylaxis. RECENT FINDINGS: Infections remain one of the leading causes of mortality in patients with PSV, with rates of severe infection ranging from 16 to 40% in different cohorts...
April 26, 2024: Current Rheumatology Reports
https://read.qxmd.com/read/38667054/incidence-outcomes-and-risk-factors-for-isoniazid-resistant-tuberculosis-from-2012-to-2022-in-eastern-china
#46
JOURNAL ARTICLE
Yan Shao, Wenlei Song, Honghuan Song, Guoli Li, Limei Zhu, Qiao Liu, Cheng Chen
BACKGROUND: Isoniazid-resistant, rifampicin-susceptible tuberculosis (Hr-TB) is the most frequent drug-resistant tuberculosis (DR-TB) in the world, and unfavorable outcomes of Hr-TB are more common compared to drug-susceptible TB. Considering there is no optimal regimen accepted worldwide, we undertook a retrospective cohort study in eastern China to estimate incidence trends and risk factors associated with unfavorable outcomes of Hr-TB. METHODS: Between January 2012 and December 2022, all Hr-TB patients' information was extracted from the Tuberculosis Information Management System (TIMS), which is a national electronic information platform, to record TB patients' clinical information in this study...
April 22, 2024: Antibiotics
https://read.qxmd.com/read/38667048/comparative-pharmacokinetics-of-gentamicin-c-1-c-1a-and-c-2-in-healthy-and-infected-piglets
#47
JOURNAL ARTICLE
Eun-Young Kim, Tae-Won Kim, Elias Gebru Awji, Eon-Bee Lee, Seung-Chun Park
Gentamicin, an aminoglycoside antibiotic, is a mixture of therapeutically active C1 , C1a , C2 and other minor components. Despite its decades-long use in pigs and other species, its intramuscular (IM) pharmacokinetics/pharmacodynamics (PKs/PDs) are unknown in piglets. Furthermore, the PKs of many drugs differ between healthy and sick animals. Therefore, we investigated the PKs of gentamicin after a single IM dose (10 mg/kg) in healthy piglets and piglets that were intranasally co-infected with Actinobacillus pleuropneumoniae and Pasteurella multocida (PM)...
April 18, 2024: Antibiotics
https://read.qxmd.com/read/38667024/concomitant-and-bismuth-quadruple-therapy-for-helicobacter-pylori-eradication-in-southern-italy-preliminary-data-from-a-randomized-clinical-trial
#48
JOURNAL ARTICLE
Giuseppe Losurdo, Antonia Valeria Borraccino, Adriana Aloisio, Francesco Russo, Giuseppe Riezzo, Grazia Galeano, Maria Pricci, Bruna Girardi, Francesca Celiberto, Andrea Iannone, Enzo Ierardi, Alfredo Di Leo
Concomitant therapy (CT) and bismuth quadruple therapy (BQT) are recommended in geographical areas with high clarithromycin resistance for Helicobacter pylori ( H. pylori ) eradication. We compared CT and BQT as the first lines of treatment in a randomized controlled trial. Consecutive patients with H. pylori diagnosed by concordance of both a urea breath test and histology were recruited. For BQT, patients received 3 PyleraTM capsules q.i.d.; for CT, 1000 mg of amoxicillin b.i.d, 500 mg of clarithromycin b...
April 10, 2024: Antibiotics
https://read.qxmd.com/read/38667020/comparative-efficacy-of-continuous-ceftazidime-infusion-vs-intermittent-bolus-against-in-vitro-ceftazidime-susceptible-and-resistant-pseudomonas-aeruginosa-biofilm
#49
JOURNAL ARTICLE
Cristina El Haj, Eugènia Agustí, Eva Benavent, Laura Soldevila-Boixader, Raül Rigo-Bonnin, Fe Tubau, Benjamín Torrejón, Jaime Esteban, Oscar Murillo
Background : As the anti-biofilm pharmacokinetic/pharmacodynamic (PK/PD) properties of antibiotics are not well-defined, we have evaluated the PK/PD indices for different regimens of ceftazidime (CAZ; with/without colistin) against Pseudomonas aeruginosa biofilm. Methods : We have used the Center for Disease Control and Prevention Biofilm Reactor with two susceptible (PAO1 and HUB-PAS) and one resistant (HUB-XDR) strains of P. aeruginosa . The regimens were CAZ monotherapies (mimicking a human dose of 2 g/8 h, CAZ-IB; 6 g/daily as continuous infusion at 50 mg/L, CAZ-CI50 ; and 9 g/daily at 70 mg/L, CAZ-CI70 ) and CAZ-colistin combinations...
April 9, 2024: Antibiotics
https://read.qxmd.com/read/38667013/-helicobacter-pylori-secondary-antibiotic-resistance-after-one-or-more-eradication-failure-a-genotypic-stool-analysis-study
#50
JOURNAL ARTICLE
Giuseppe Losurdo, Martino Mezzapesa, Ilaria Ditonno, Mariapaola Piazzolla, Maria Pricci, Bruna Girardi, Francesca Celiberto, Grazia Galeano, Giuseppe Riezzo, Francesco Russo, Andrea Iannone, Enzo Ierardi, Alfredo Di Leo
Helicobacter pylori ( H. pylori ) antibiotic resistance is the leading cause for unsuccessful eradication therapy. After one or more failures, the chance of encountering secondary antibiotic resistance increases. The aim of this study was to characterize genotypic secondary resistance in a cohort of southern Italian H. pylori patients with at least one previous failure. Such patients collected stool samples using a dedicated kit (THD fecal testTM ), and bacterial DNA was extracted and amplified using RT-PCR...
April 7, 2024: Antibiotics
https://read.qxmd.com/read/38667012/revisiting-the-checkerboard-to-inform-development-of-%C3%AE-lactam-%C3%AE-lactamase-inhibitor-combinations
#51
JOURNAL ARTICLE
Darren J Bentley
A two-dimensional "checkerboard" array employing systematic titration (e.g., serial two-fold dilutions) is a well-established in vitro method for exploring the antibacterial effects of novel drug combinations. Minimum inhibitory concentrations (MICs) on the checkerboard are isoeffective points at which the antibiotic potency is the same. Representations of checkerboard MIC curves for a β-lactam and β-lactamase inhibitor combination are used in hypothetical "thought experiments" and reveal the ways in which current practices can be improved...
April 7, 2024: Antibiotics
https://read.qxmd.com/read/38667003/dalbavancin-for-acute-bacterial-skin-and-skin-structure-infections-in-pediatrics-insights-from-continuation-therapy-experience
#52
Sara Maria Scarano, Eugenia Bruzzese, Marco Poeta, Margherita Del Bene, Alfredo Guarino, Andrea Lo Vecchio
Acute Bacterial Skin and Skin Structure Infections (ABSSSI) are marked by substantial morbidity, frequent need for hospitalization, and long courses of intravenous antibiotic therapy. Herein, we report four cases of pediatric patients admitted for ABSSSI and managed with a combination antibiotic regimen incorporating dalbavancin: a second-generation lipoglycopeptide active against Gram-positive bacteria, including methicillin-resistant Staphylococcus aureus . In our experience, particularly in a setting with a high methicillin-resistance rate, dalbavancin demonstrated safety and efficacy, simplifying ABSSSI management in childhood...
April 4, 2024: Antibiotics
https://read.qxmd.com/read/38666989/dosing-regimen-for-cefotaxime-should-be-adapted-to-the-stage-of-renal-dysfunction-in-critically-ill-adult-patients-a-retrospective-study
#53
JOURNAL ARTICLE
Théo Dillies, Sophie Perinel-Ragey, Patricia Correia, Jérôme Morel, Guillaume Thiery, Manon Launay
Cefotaxime administration is recommended in doses of 3-12 g/day in adults with a Glomerular Filtration Rate (GFR) > 5 mL/min. This study aimed to assess the impact of renal function and obesity on cefotaxime concentrations in intensive care unit (ICU) patients. A retrospective cohort study was conducted on consecutive ICU patients receiving continuous cefotaxime infusion between 2020 and 2022 [IRBN992021/CHUSTE]. Doses were not constant; consequently, a concentration-to-dose ratio (C/D) was considered. Statistical analysis was performed to assess the relationship between cefotaxime concentrations, renal function, and obesity...
March 29, 2024: Antibiotics
https://read.qxmd.com/read/38666978/characterizing-antibiotic-regimen-modification-behavior-patient-characteristics-and-outcomes-for-patients-with-gram-negative-bacterial-infections-a-retrospective-single-center-study
#54
JOURNAL ARTICLE
Jason Yamaki, Mirna Mikhail, Richard Beuttler, Philip Robinson, Emre Yücel, Alexandre H Watanabe
Few studies describe the frequency of antibiotic regimen modification behaviors in the acute care setting. We sought to ascertain patient and treatment characteristics, details of regimen modification, and clinical outcomes with antibiotic modifications. This retrospective study included patients admitted to Hoag Memorial Hospital from 1 January 2019-31 March 2021 with a complicated infection caused by a Gram-negative organism resistant to extended-spectrum cephalosporins or with the potential for resistance (AmpC producers)...
March 27, 2024: Antibiotics
https://read.qxmd.com/read/38666474/daptomycin-exposure-prediction-with-a-limited-sampling-strategy
#55
JOURNAL ARTICLE
Simona De Gregori, Elena Seminari, Mara Capone, Paola Giordani, Rsffaele Bruno, Annalisa De Silvestri
BACKGROUND: Daptomycin is a cyclic lipopeptide antibiotic used to treat serious infectious endocarditis caused by Staphylococcus aureus. The pharmacodynamic parameter correlating best with efficacy is the ratio of the estimated area under the concentration (AUC0-24)-time curve to the minimum inhibitory concentration. The aim of the study is to develop a limited sampling strategy to estimate AUC0-24 using a reduced number of samples. METHODS: Sixty-eight daptomycin AUC0-24 values were calculated for 50 White patients who underwent treatment for at least 5 consecutive days...
April 25, 2024: Therapeutic Drug Monitoring
https://read.qxmd.com/read/38665174/real-world-effectiveness-of-intravenous-and-oral-antibiotic-stepdown-strategies-for-gram-negative-complicated-urinary-tract-infection-with-bacteremia
#56
John J Veillette, Stephanie S May, Sameer Alzaidi, Jared Olson, Allison M Butler, C Dustin Waters, Katarina Jackson, Mary A Hutton, Brandon J Webb
BACKGROUND: Robust data are lacking regarding the optimal route, duration, and antibiotic choice for gram-negative bloodstream infection from a complicated urinary tract infection source (GN-BSI/cUTI). METHODS: In this multicenter observational cohort study, we simulated a 4-arm registry trial using a causal inference method to compare effectiveness of the following regimens for GN-BSI/cUTI: complete course of an intravenous β-lactam (IVBL) or oral stepdown therapy within 7 days using fluoroquinolones (FQs), trimethoprim-sulfamethoxazole (TMP-SMX), or high-bioavailability β-lactams (HBBLs)...
April 2024: Open Forum Infectious Diseases
https://read.qxmd.com/read/38662994/filgrastim-use-in-the-treatment-of-azathioprine-induced-myelosuppression-toxicity-after-prescription-error-in-the-feline
#57
JOURNAL ARTICLE
Leigh Klar
Only one report on the successful use of filgrastim (granulocyte colony-stimulating factor) in cats for severe neutropenia following azathioprine toxicity exists. Here, we report on a case in which a cat was prescribed methimazole but the medication was filled incorrectly with azathioprine tablets and the prescription label indicated a methimazole dosing regimen that was administered for three days before recognition of the error. On presentation, the cat's physical examinations were consistent with previous examinations before ingestion of azathioprine...
May 1, 2024: Journal of the American Animal Hospital Association
https://read.qxmd.com/read/38662091/efficacy-and-safety-of-antibiotics-targeting-gram-negative-bacteria-in-nosocomial-pneumonia-a-systematic-review-and-bayesian-network-meta-analysis
#58
JOURNAL ARTICLE
David Luque Paz, Dara Chean, Pierre Tattevin, Damien Luque Paz, Betsega Assefa Bayeh, Achille Kouatchet, Delphine Douillet, Jérémie Riou
BACKGROUND: Multiple randomized controlled studies have compared numerous antibiotic regimens, including new, recently commercialized antibiotics in the treatment of nosocomial pneumonia (NP). The objective of this Bayesian network meta-analysis (NMA) was to compare the efficacy and the safety of different antibiotic treatments for NP. METHODS: We conducted a systematic search of PubMed, Medline, Web of Science, EMBASE and the Cochrane Library databases from 2000 through 2021...
April 25, 2024: Annals of Intensive Care
https://read.qxmd.com/read/38661207/is-shorter-also-better-in-the-treatment-of-clostridioides-difficile-infection
#59
JOURNAL ARTICLE
M Duricek, K Halmova, M Krutova, B Sykorova, J Benes
OBJECTIVES: To assess the effectiveness of shortened regimens of vancomycin or fidaxomicin in the treatment of Clostridioides difficile infection (CDI). METHODS: Adult patients with CDI hospitalized from January 2022 to May 2023 were included in this observational study. In patients with CDI treated with vancomycin or fidaxomicin, antibiotic treatment was discontinued after either 5 or 7 days of vancomycin or 5 days of fidaxomicin if there was a clinical response and improvement in laboratory parameters...
April 25, 2024: Journal of Antimicrobial Chemotherapy
https://read.qxmd.com/read/38659251/comparison-of-the-efficacy-of-12-day-concomitant-quadruple-therapy-versus-14-day-high-dose-dual-therapy-as-a-first-line-h-pylori-eradication-regimen
#60
RANDOMIZED CONTROLLED TRIAL
Seyed Mohammad Valizadeh Toosi, Sahar Feyzi, Arash Kazemi
BACKGROUND/AIMS: Helicobacter pylori ( H. pylori ) is the most prevalent infection in the world and is strongly associated with gastric adenocarcinoma, lymphoma and gastric or duodenal ulcers. Different regimens have been used for H. pylori eradication. We aimed to compare the efficacy of two different regimens as first-line H. pylori eradication regimens, in an area with high antibiotic resistance. METHODS: In this RCT, we assigned 223 patients with H. pylori infection, who were naïve to treatment...
April 25, 2024: Korean Journal of Gastroenterology, Taehan Sohwagi Hakhoe Chi
keyword
keyword
73683
3
4
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.